The Democratic Republic of Congo and the United States have signed a $1.2bn strategic health agreement aimed at strengthening the country’s healthcare system and expanding disease prevention programmes over the next five years, according to a joint statement issued Thursday.
The partnership, covering the period from 2026 to 2031, combines $900m in targeted assistance from the US government with a commitment by Kinshasa to contribute $300m through progressively increased domestic health expenditure.
Officials from both governments described the agreement as a long-term investment designed to improve healthcare delivery while encouraging greater national ownership of public health financing.
The deal reflects a broader evolution in international health cooperation, where donor funding is increasingly tied to domestic financial commitments. For the Democratic Republic of Congo — a country facing recurring disease outbreaks and structural healthcare challenges — the agreement represents both critical external support and a pathway toward stronger health sovereignty.
According to the joint statement, the partnership will prioritise programmes addressing HIV/AIDS, tuberculosis and malaria, which remain among the country’s most pressing public health concerns.
The agreement also includes initiatives supporting maternal and child health, polio eradication, epidemiological surveillance, health workforce development, and emergency preparedness and response systems.
Congolese health authorities said the investment is intended to improve care outcomes while building institutional capacity to manage future health crises.
In a message posted on social media platform X, the country’s health ministry said the initiative represents a ‘structural investment’ aimed at strengthening healthcare resilience and consolidating national healthcare sovereignty.
Public health experts note that the Democratic Republic of Congo has faced repeated outbreaks of infectious diseases in recent years, highlighting the importance of improved monitoring and rapid-response systems.
The partnership is expected to enhance disease surveillance infrastructure and expand training for healthcare workers, areas seen as critical to preventing health emergencies from escalating into regional crises.
Officials said coordinated monitoring mechanisms will track progress throughout the implementation period.
The agreement follows a funding model increasingly used by Washington across African health partnerships, combining foreign assistance with mandatory domestic investment commitments intended to promote sustainability.
However, similar arrangements have recently encountered resistance in other countries.
On Wednesday, Zimbabwe withdrew from negotiations over a proposed $367m bilateral health agreement with the United States, citing concerns about provisions involving the sharing of sensitive health data in exchange for financial support. A government spokesperson described the proposal as an ‘unequal exchange’.
In Kenya, a court late last year suspended implementation of a health funding deal worth more than $1.6bn signed with Washington, pending a legal challenge filed by a consumer protection group that raised concerns about data privacy and the protection of citizens’ health information.
Despite controversies elsewhere, Congolese officials framed the new agreement as a step toward greater independence in healthcare financing and management.
By pairing international assistance with domestic investment, policymakers aim to ensure programmes remain sustainable beyond donor funding cycles while improving nationwide healthcare access.
Analysts say the success of the partnership will depend on effective implementation, transparency and sustained political commitment from both governments.
The joint statement emphasised that cooperation between Kinshasa and Washington will continue to evolve as programmes roll out through 2031, with shared accountability mechanisms guiding progress and evaluation.
